Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-15

My take on things is:

• The SureScreen Diagnostics (UK) RAT with Rhinoswab looks like it has TGA approval (for Australia).
• The BTNX (Canadian) RAT with Rhinoswab looks like it's still awaiting Canadian & TGA approval (as per 7/4/22 announcement).
• But in the meantime RNO has been ramping up production
• SureScreen Australia does the distribution for BTNX in Australia
• SureScreen Australia does the distribution for SureScreen Diagnostics in Australia
• At this stage I don't think there is another UK company - I think it's SureScreen Diagnostics that RNO is talking about.

It's possible that RNO is also talking to SureScreen Diagnostics (UK) about a UK supply deal and/or manufacturing, as they have hinted about having more manufacturing sites.

Whilst they have some distribution arrangements together, I wouldn't see BTNX & SureScreen as one entity. For example think of RNO's deal with BTNX. It is exclusive for the Canadian market & non exclusive in other markets. So in Australia we are potentially free to sign up with BTNX's RAT & with SureScreen's RAT. But in the Canadian markets RNO can only deal with BTNX's RAT.